ES2059882T3 - Preparacion de la sustancia fr 115224 para administracion parenteral. - Google Patents

Preparacion de la sustancia fr 115224 para administracion parenteral.

Info

Publication number
ES2059882T3
ES2059882T3 ES90110339T ES90110339T ES2059882T3 ES 2059882 T3 ES2059882 T3 ES 2059882T3 ES 90110339 T ES90110339 T ES 90110339T ES 90110339 T ES90110339 T ES 90110339T ES 2059882 T3 ES2059882 T3 ES 2059882T3
Authority
ES
Spain
Prior art keywords
substance
preparation
parenteral administration
cyclodextrin
preparing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90110339T
Other languages
English (en)
Inventor
Sotoo Asakura
Nobuto Kanagawa
Youhei Kiyota
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fujisawa Pharmaceutical Co Ltd
Original Assignee
Fujisawa Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co Ltd filed Critical Fujisawa Pharmaceutical Co Ltd
Application granted granted Critical
Publication of ES2059882T3 publication Critical patent/ES2059882T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/81—Carrier - bound or immobilized peptides or proteins and the preparation thereof, e.g. biological cell or cell fragment as carrier
    • Y10S530/812—Peptides or proteins is immobilized on, or in, an organic carrier
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/81—Carrier - bound or immobilized peptides or proteins and the preparation thereof, e.g. biological cell or cell fragment as carrier
    • Y10S530/812—Peptides or proteins is immobilized on, or in, an organic carrier
    • Y10S530/813—Carrier is a saccharide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Nanotechnology (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Pulmonology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

UNA PREPARACION PARA ADMINISTRACION PARENTERICA QUE CONTIENE SUBSTANCIA FR115224 Y CICLODEXTRINA Y PROCESOS PARA PREPARARLA.
ES90110339T 1989-06-02 1990-05-31 Preparacion de la sustancia fr 115224 para administracion parenteral. Expired - Lifetime ES2059882T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP14197289 1989-06-02

Publications (1)

Publication Number Publication Date
ES2059882T3 true ES2059882T3 (es) 1994-11-16

Family

ID=15304406

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90110339T Expired - Lifetime ES2059882T3 (es) 1989-06-02 1990-05-31 Preparacion de la sustancia fr 115224 para administracion parenteral.

Country Status (11)

Country Link
US (1) US5093127A (es)
EP (1) EP0400637B1 (es)
JP (1) JP2987883B2 (es)
KR (1) KR910000165A (es)
AT (1) ATE96331T1 (es)
AU (1) AU644588B2 (es)
CA (1) CA2017156A1 (es)
DE (1) DE69004151T2 (es)
DK (1) DK0400637T3 (es)
ES (1) ES2059882T3 (es)
ZA (1) ZA903856B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0498069T3 (da) * 1990-12-21 1995-12-04 Fujisawa Pharmaceutical Co Ny anvendelse af peptidderivat
US5494901A (en) * 1993-01-05 1996-02-27 Javitt; Jonathan C. Topical compositions for the eye comprising a β-cyclodextrin derivative and a therapeutic agent
WO1994020126A1 (en) * 1993-03-03 1994-09-15 Fujisawa Pharmaceutical Co., Ltd. Use of peptides for the manufacture of a medicament
WO1996001558A1 (en) * 1994-07-11 1996-01-25 Pate David W Anandamide analogue compositions and method of treating intraocular hypertention using same
US5631297A (en) * 1994-07-11 1997-05-20 Pate; David W. Anandamides useful for the treatment of intraocular hypertension, ophthalmic compositions containing the same and methods of use of the same
US6123932A (en) * 1999-06-14 2000-09-26 The Procter & Gamble Company Deodorant compositions containing cyclodextrin odor controlling agents

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU181703B (en) * 1980-05-09 1983-11-28 Chinoin Gyogyszer Es Vegyeszet Process for producing aqueus solutuins of water insoluble or hardly soluble vitamines, steroides, localanesthetics, prostanoides and non-steroid and antiphlogistic agents
HU201685B (en) * 1987-04-23 1990-12-28 Chinoin Gyogyszer Es Vegyeszet For producing pharmaceutical compositions for inhalation and compositions for scenting air containing volatile active component in cyclodextrine inclusion, and air-scenting composition
GB2226023A (en) * 1988-11-29 1990-06-20 Glaxo Group Ltd Optical isomers of thromboxane antagonist prostanoids
GB8807921D0 (en) * 1988-04-05 1988-05-05 Fujisawa Pharmaceutical Co Ws-9326 & its derivatives
JPH0742313B2 (ja) * 1988-03-28 1995-05-10 日立化成工業株式会社 新規ペプチド、その塩及びペプチド性抗アレルギー剤

Also Published As

Publication number Publication date
CA2017156A1 (en) 1990-12-02
ATE96331T1 (de) 1993-11-15
ZA903856B (en) 1991-05-29
AU644588B2 (en) 1993-12-16
US5093127A (en) 1992-03-03
JPH0386833A (ja) 1991-04-11
JP2987883B2 (ja) 1999-12-06
AU5604790A (en) 1990-12-06
EP0400637B1 (en) 1993-10-27
EP0400637A2 (en) 1990-12-05
DE69004151D1 (de) 1993-12-02
KR910000165A (ko) 1991-01-29
DE69004151T2 (de) 1994-03-24
EP0400637A3 (en) 1991-07-03
DK0400637T3 (da) 1993-12-06

Similar Documents

Publication Publication Date Title
HUT59000A (en) Process for producing pharmaceutical preparations containing 4-phenyl-1,2,3,4-tetrahydro-1-naphtalinamine-derivatives
BR8902297A (pt) Processo para a preparacao de 1,1,1,2-tetrafluoretano
BR8803759A (pt) Processo para a preparacao de 2,2,6,6-tetrametil-4-piperidilaminas
IT8720059A0 (it) Process per la preparazione di (2,2)-paraciclofano e suoi derivati.
PT89705A (pt) Processo para a preparacao de 2', 3'-didesoxi-2', 2'-difluoronucleosidos
BR9003345A (pt) Processo para a preparacao de 1,1,1,2-tetrafluoretano
ES2021411B3 (es) Proceso para la preparacion de (2,2) paraciclofano.
PT93803A (pt) Processo para a preparacao de uma solucao aquosa concentrada de glutaraldeido e 1,2-benzisotiazolin-3-ona
FI894546A (fi) Menetelmä uusien 2'-halogeenimetylideeni-, 2'-etenylideeni- ja 2'-etynyyliadenosiinijohdannaisten valmistamiseksi
DE69006911D1 (de) Verfahren zur Herstellung von 3,4-Dichloranilin.
ES2059882T3 (es) Preparacion de la sustancia fr 115224 para administracion parenteral.
PT93736A (pt) Processo para a preparacao de n,n'-ditrimetoxi-benzoil-piperazinas 2- substituidas
FI895662A0 (fi) Menetelmä 3,4-difluorisubstituoidun benseenin valmistamiseksi
MX9200469A (es) Proceso de dos etapas para la preparacion de 2,2,6,6-tetrametil-4-piperidilaminas
MX17107A (es) Procedimiento para la preparacion de tiazolo-(1,5)-benzodiazepinas y producto obtenido
IT1216560B (it) Procedimento per la preparazione di bis(2,2,6,6_tetrametil_4_piperidil)ammina.
BR9003346A (pt) Processo para a preparacao de 1,2-dicloro-1,1,2-trifluoretano
NO903347D0 (no) Fremgangsmaate for fremstilling av 14,17alfa-ethano- og ethanooestratriener.
EP0421216A3 (en) Process for the preparation of 2,4, resp. 2,6 dihalo-aniline
EP0334097A3 (en) Process for the preparation of 4,4'-dihalogeno-bisphenyls
PT84750B (pt) Processo de preparacao de uma composicao para o envenenamento de roedores, a base de derivados de 1,4-naftoquinona
IL92465A0 (en) Process for the preparation of 4,4'-dibromodiphenylether
BR9100045A (pt) Processo para a preparacao de 1,1,1,2,2-pentafluoro-3,3-dicloropropano e 1,1,2,2,3-pentafluoro-1,3-dicloropropano
MA21272A1 (fr) Derives d'oximino ethers.
BR9007499A (pt) Processo para a preparacao de 2,4,6-trifluor-1,3,5-triazina

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 400637

Country of ref document: ES